Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 82

    Lupin: FIRST to win Canadian approval for generic version of Inderal-LA capsules

    Lupin: FIRST to win Canadian approval for generic version of Inderal-LA capsules

    Farhat Nasim14 Sept 2019 9:45 AM IST
    Lupin is the first generic company to receive approval for generic Inderal-LA capsules for the Canadian market and the product will be manufactured at...
    Pharmexcil DG Uday Bhasker sees Indian pharma exports at USD 22 billion in fiscal 2019-20

    Pharmexcil DG Uday Bhasker sees Indian pharma exports at USD 22 billion in fiscal 2019-20

    Medical Dialogues Bureau14 Sept 2019 9:16 AM IST
    Director-general of Pharmexcil, a body under the Ministry of Commerce and Industry, Uday Bhasker said some of the policy decisions being taken by the...
    Bayer, Monsanto India mega-merger worth USD 63 billion gets clearance from NCLT

    Bayer, Monsanto India mega-merger worth USD 63 billion gets clearance from NCLT

    Medical Dialogues Bureau14 Sept 2019 9:15 AM IST
    Bayer CropScience took shareholders' approval for the merger during the first quarter of 2019-20 and was waiting for the final approval of the NCLT to...
    Carcinogen in popular heartburn drug Zantac triggers safety review by European, US regulators

    Carcinogen in popular heartburn drug Zantac triggers safety review by European, US regulators

    Medical Dialogues Bureau14 Sept 2019 9:15 AM IST
    Valisure said in its report that it found the impurity in both Sanofi SA's branded Zantac as well as generic versions of the drug. But the FDA would...
    Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada

    Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada

    Medical Dialogues Bureau13 Sept 2019 11:59 AM IST
    The company has received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at the formulations...
    First AI-powered X-ray System: GE Healthcare bags USFDA approval

    First AI-powered X-ray System: GE Healthcare bags USFDA approval

    Medical Dialogues Bureau13 Sept 2019 9:30 AM IST
    Built-in collaboration with UC San Francisco (UCSF), using GE Healthcare's Edison platform, the AI algorithms help to reduce the turn-around time it...
    Investigate, block AbbVie, Allergan USD 63 billion merger: Consumer Groups to Trade Commission

    Investigate, block AbbVie, Allergan USD 63 billion merger: Consumer Groups to Trade Commission

    Medical Dialogues Bureau13 Sept 2019 9:20 AM IST
    The combination of two of the world's biggest pharmaceutical companies, which was announced in June, would feature a portfolio that includes the...
    Aspen Pharma gets USFDA nod for HPC to prevent preterm birth in pregnant women

    Aspen Pharma gets USFDA nod for HPC to prevent preterm birth in pregnant women

    Medical Dialogues Bureau13 Sept 2019 9:15 AM IST
    Aspen, which operates in about 56 countries, has said before that it views the United States as presenting targeted growth opportunities for its niche...
    USFDA okays Xeris Pharma glucagon pen Gvoke to treat low blood sugar

    USFDA okays Xeris Pharma glucagon pen Gvoke to treat low blood sugar

    Medical Dialogues Bureau13 Sept 2019 9:00 AM IST
    Xeris Pharma's Gvoke, a glucagon pen is a pre-filled device with a liquid stable form of glucagon.U.S: The U.S. Food and Drug Administration has...
    Oops! Salmonella bacteria found in MDH sambar masala, USFDA orders recall

    Oops! Salmonella bacteria found in MDH sambar masala, USFDA orders recall

    Farhat Nasim12 Sept 2019 3:52 PM IST
    "The MDH sambhar masala recall was initiated after it was discovered by the USFDA that the salmonella contaminated products were distributed," the...
    Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake

    Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake

    Medical Dialogues Bureau12 Sept 2019 10:00 AM IST
    The company's step-down subsidiary Strides Pharma Global has acquired a majority stake in Fairmed Healthcare AG which has a portfolio of generic...
    Alkem Labs gets EIR from USFDA for St.Louis facility

    Alkem Labs gets EIR from USFDA for St.Louis facility

    Medical Dialogues Bureau12 Sept 2019 9:30 AM IST
    "In furtherance to the intimation captioned "US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA" dated 23rd August, 2019,...
    PrevNext

    Popular Stories

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Novo Nordisk names Vikrant Shrotriya as Managing Director for India business

    Novo Nordisk names Vikrant Shrotriya as Managing Director for India business

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok